Skip to content

liuosta varten

DRUG13 trials

Sponsors

Gilead Sciences Inc., F. Hoffmann-La Roche AG, Centre Hospitalier Intercommunal Creteil, Turku University Hospital, HUS-Yhtymae

Conditions

Adolescent idiopathic scoliosis (AIS)Advanced Non-Small Cell Lung CancerCancerChronic Lymphocytic Leukemia (CLL)Diabetic Foot OsteomyelitisDiffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCLDiffuse large B-cell lymphomas (DLBCLHigh-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiation

Phase 2

Phase 3

A Prospective, Open-Label, Multicenter Randomized Phase III Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine and Rituximab (BR) in FIT Patients with previously untreated Chronic Lymphocytic Leukemia (CLL) without DEL(17P) or TP53 Mutation
CompletedCTIS2023-504036-17-00
F. Hoffmann-La Roche AGChronic Lymphocytic Leukemia (CLL)
Start: 2020-05-07End: 2025-03-18Target: 121Updated: 2025-04-17
Antibiotic Treatment Trial in Acute Coronary Syndrome
Not yet recruitingCTIS2025-522136-14-00
TAYS Sydaenkeskus Oycoronary artery disease, non-ST-elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI)
Target: 1070Updated: 2025-08-27
Continuous antibiotic infusion in children
Not yet recruitingCTIS2025-522809-38-00
Pirkanmaan hyvinvointialueInfection disease
Target: 150Updated: 2026-02-16
Double blind, multicenter, randomized, controlled trial of dexmedetomidine vs placebo in premature neonates receiving invasive ventilation
Not yet recruitingCTIS2023-509247-27-00
Centre Hospitalier Intercommunal CreteilNeonatal respiratory distress. Pain and discomfort
Target: 246Updated: 2026-02-18
LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospective, Randomized, Controlled Trial
Not yet recruitingCTIS2025-524723-52-00
Pirkanmaan hyvinvointialueDiabetic Foot Osteomyelitis
Target: 84Updated: 2026-04-10

Phase 4